aristolochic acid i and epoetin alfa

aristolochic acid i has been researched along with epoetin alfa in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angeletti, A; Cantarelli, C; Cravedi, P; D'Agati, VD; Donadei, C; Fiaccadori, E; Guglielmo, C; Hartzell, S; Heeger, PS; Horwitz, JK; La Manna, G; Madsen, JC; Maggiore, U; Xiong, H1

Other Studies

1 other study(ies) available for aristolochic acid i and epoetin alfa

ArticleYear
Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease.
    JCI insight, 2019, 04-23, Volume: 5

    Topics: Animals; Aristolochic Acids; Cells, Cultured; Disease Models, Animal; Epoetin Alfa; Erythropoietin; Female; Humans; Immediate-Early Proteins; Interleukin-17; Lupus Nephritis; Male; Mice; Mice, Inbred MRL lpr; Mice, Transgenic; Nephritis, Interstitial; Phosphorylation; Primary Cell Culture; Protein Serine-Threonine Kinases; Receptors, Erythropoietin; Receptors, Interleukin; Severity of Illness Index; T-Lymphocytes, Regulatory; Th17 Cells

2019